Huntsman Ronald Kirk 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Vivos Therapeutics, Inc. VVOS |
Huntsman Ronald Kirk | 90,033 9.000% |
1,480 (+1.67%) |
Filing |
| 2022-02-14 5:03 pm Purchase |
2021-12-31 | 13G | Vivos Therapeutics, Inc. VVOS |
Huntsman Ronald Kirk | 88,553 9.620% |
5,200 (+6.24%) |
Filing |
| 2021-02-16 2:32 pm Purchase |
2020-12-31 | 13G | Vivos Therapeutics, Inc. VVOS |
Huntsman Ronald Kirk | 83,353 11.500% |
83,353 (New Position) |
Filing |